BioNTech SE (22UA) — Financial Flexibility Index
BioNTech SE (22UA) has a Financial Flexibility Index of -0.14x as of March 2026. Free cash flow of €-342.10 Million (operating CF €-421.00 Million minus capex €78.90 Million) represents 0% of total liabilities (€2.38 Billion). Also explore BioNTech SE equity growth rate to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
BioNTech SE Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for BioNTech SE across 9 annual periods. Check BioNTech SE strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for BioNTech SE (2017–2025)
Year-by-year free cash flow to debt coverage for BioNTech SE. For the full company profile including market capitalisation, see BioNTech SE stock valuation.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.44x | €1.21 Billion | €456.00 Million | €2.76 Billion | ▲ +106.0% |
| 2024 | 0.21x | €660.00 Million | €207.70 Million | €3.12 Billion | ▼ -90.4% |
| 2023 | 2.20x | €6.08 Billion | €5.37 Billion | €2.76 Billion | ▼ -49.1% |
| 2022 | 4.32x | €13.94 Billion | €13.58 Billion | €3.22 Billion | ▲ +1573.9% |
| 2021 | 0.26x | €1.02 Billion | €889.70 Million | €3.94 Billion | ▲ +365.9% |
| 2020 | 0.06x | €52.50 Million | €-13.50 Million | €946.77 Million | ▲ +110.5% |
| 2019 | -0.53x | €-159.90 Million | €-198.50 Million | €304.15 Million | ▼ -600.3% |
| 2018 | -0.08x | €-28.98 Million | €-58.88 Million | €385.99 Million | ▼ -12.4% |
| 2017 | -0.07x | €-28.24 Million | €-52.56 Million | €422.92 Million | — |